Skip to content

Effects of Electroacupuncture at the Zusanli Acupuncture Point on Inflammatory Response and Organ Injury in Postoperative Cardiac Surgery Patients: A Prospective Randomized Parallel-Controlled Single-Center Study

The Impact of Electroacupuncture Stimulation at the Zusanli Acupoint on Inflammatory Responses and Organ Dysfunction in Patients Following Cardiac Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000693
Enrollment
Unknown
Registered
2024-11-12
Start date
2024-06-30
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Inflammatory Response After Cardiac Surgery

Interventions

ontrol group:not applicable
intervention group:electroacupuncture stimulation at ST36

Sponsors

Department of Critical Care Medicine Sir Run Run Shaw Hospital Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients admitted to the Department of Cardiac Surgery at Sir Run Run Shaw Hospital affiliated with Zhejiang University School of Medicine who are 18 years of age or older and are scheduled to undergo emergency or elective cardiac surgery requiring intraoperative cardiopulmonary bypass support including patients undergoing coronary artery bypass grafting valve replacement and valvuloplasty procedures.

Exclusion criteria

Exclusion criteria: Age > 85 years or pregnant and lactating patients; local skin and soft tissue infections or erysipelas cannot undergo acupuncture treatment at Zusanli (ST36). Patients who have undergone organ transplantation malignant tumors long-term treatment with high doses of glucocorticoids (equivalent to prednisone =20 mg/day for =14 days or cumulative equivalent prednisone dose >700 mg); patients with severe chronic organ dysfunction including (chronic respiratory diseases with a baseline oxygenation index (PaO2/FiO2) below 400 mmHg; leukemia lymphoma myeloma or a baseline platelet count below 100×109/L; excluding chronic liver diseases with total bilirubin levels above 30 µmol/L; excluding patients with a history of stroke cerebral hemorrhage and Glasgow Coma Scale (GCS) below 10; excluding patients with chronic kidney disease with creatinine levels above 110 µmol/L/long-term daily urine volume less than 500 ml); others such as unwillingness to participate in the study or cooperate with treatment. Patients who cannot tolerate electroacupuncture treatment or are lost to follow-up due to other concurrent diseases during the study will be withdrawn; those participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
CRP;

Secondary

MeasureTime frame
Whole Blood Infection and Inflammatory Markers;ICU days;Duration of no mechanical ventilation within 72 hours;SIRS;72-hour CRRT-free days;72-hour Vasoactive Medication-Free Days;

Countries

China

Contacts

Public ContactZhoujiancang

Department of Critical Care Medicine Sir Run Run Shaw Hospital Zhejiang University School of Medicine

jiancangzhou@zju.edu.cn13867413145

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026